Researchers have identified in a new study that increased day-to-day blood pressure variability (BPV) is independently ...

Morepen Laboratories Limited announces the launch of Empamore, a game-changing treatment for Type 2 Diabetes Mellitus, Heart ...

Discover the life-extending approaches to managing heart failure through medication adherence, lifestyle modifications, and ...

Heart conditions can be difficult to diagnose, often requiring specialised tools to provide a clear picture of a patient’s heart health. Among the most effective methods is the echo test for heart, ...

Montelaro. Worsening heart failure events are associated with new initiation of guideline directed medical therapy among patients with heart failure with reduced ejection fraction. A. Ambrosy.

Merck , known as MSD outside of the United States and Canada, today announced that new clinical and outcomes research data will be presented at the American College of Cardiology's Annual Scientific ...

BACKGROUND: Limited evidence exists on the prognostic role of continuing medical therapy in patients with heart failure (HF) and an ejection fraction (EF) that has improved over time. This study ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for finerenone for the treatment of ...

Inter-atrial shunt device therapy has shown mixed results in clinical trials, with clinical 'non-responders' typically showing features of more advanced heart failure. We aimed to analyse the ...

The PREDICT-HFpEF tool predicts cardiovascular risk, and finerenone remains effective for heart failure across baseline risk levels.